BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21148756)

  • 21. The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping.
    Heckmann M; Holle JU; Arning L; Knaup S; Hellmich B; Nothnagel M; Jagiello P; Gross WL; Epplen JT; Wieczorek S
    Ann Rheum Dis; 2008 Jul; 67(7):972-9. PubMed ID: 17967832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
    Bretherick KL; Schuetz JM; Morton LM; Purdue MP; Conde L; Gallagher RP; Connors JM; Gascoyne RD; Berry BR; Armstrong B; Kricker A; Vajdic CM; Grulich A; Hjalgrim H; Smedby KE; Skibola CF; Rothman N; Spinelli JJ; Brooks-Wilson AR
    PLoS One; 2013; 8(9):e74619. PubMed ID: 24069324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.
    Ten LC; Chin YM; Tai MC; Chin EF; Lim YY; Suthandiram S; Chang KM; Ong TC; Bee PC; Mohamed Z; Gan GG; Ng CC
    Sci Rep; 2017 Jan; 7():41400. PubMed ID: 28139690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
    Shen M; Zheng T; Lan Q; Zhang Y; Zahm SH; Wang SS; Holford TR; Leaderer B; Yeager M; Welch R; Kang D; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S; Rothman N
    Hum Genet; 2006 Jul; 119(6):659-68. PubMed ID: 16738949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
    Ye X; Zhao K; Wu C; Hu P; Fu H
    Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
    Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
    PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
    Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
    Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
    Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
    Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
    Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
    PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
    Hosgood HD; Purdue MP; Wang SS; Zheng T; Morton LM; Lan Q; Menashe I; Zhang Y; Cerhan JR; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Schenk M; Zahm SH; Chatterjee N; Chanock SJ; Rothman N; Hartge P; Armstrong B
    Br J Haematol; 2011 Mar; 152(6):721-6. PubMed ID: 21250972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
    Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
    Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between non-Hodgkin lymphoma and haplotypes in the TNF region.
    Spink CF; Keen LJ; Mensah FK; Law GR; Bidwell JL; Morgan GJ
    Br J Haematol; 2006 May; 133(3):293-300. PubMed ID: 16643431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma.
    Ng CH; Janoo-Gilani R; Sipahimalani P; Gallagher RP; Gascoyne RD; Connors JM; Weber JP; Lai AS; Leach S; Le ND; Brooks-Wilson AR; Spinelli JJ
    Cancer Causes Control; 2010 Jan; 21(1):11-22. PubMed ID: 19821039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.
    Peckham-Gregory EC; Thapa DR; Martinson J; Duggal P; Penugonda S; Bream JH; Chang PY; Dandekar S; Chang SC; Detels R; Martínez-Maza O; Zhang ZF; Hussain SK
    Cancer Epidemiol; 2016 Dec; 45():47-57. PubMed ID: 27701053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
    Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
    Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
    Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
    Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.